Department of Interventional Neuroradiology, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, 100053 Beijing, China.
Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 100053 Beijing, China.
J Neuroradiol. 2018 Sep;45(5):295-304. doi: 10.1016/j.neurad.2017.12.023. Epub 2018 Feb 2.
The optimal treatment of chronic symptomatic total occlusion of the intracranial vertebral artery (ICVA) remains undefined. We report a single-center experience of endovascular recanalization for patients with chronic symptomatic ICVA occlusion who were refractory to medical therapy.
From Jan 2009 to Jan 2017, we retrospectively reviewed 14 consecutive patients presenting with recurrent symptoms attributed to the chronic ICVA occlusion. We searched previous literature using PubMed databases during the same period as comparison.
Eleven patients out of 14 presented initial symptoms to intervention less than 90days. The occlusion course was extrapolated on simultaneous two-vessel injection angiography or high-resolution MR imaging (HRMRI) in 13 cases. Nine patients had the occlusion beyond the origin of posterior inferior cerebellar artery (PICA) and 5 had the occlusion proximal to the PICA origin. The technical success rate of recanalization was 85.7% (12/14). Two patients (14.3%, 2/14) had peri-procedural complications: 1 developed TIA and 1 presented with perforator occlusion syndrome. Using the keyword-based search, we identified 6 studies at the same period. A total of 34 patients underwent recanalization with the successful recanalization rate at 94.1%, peri-procedural complication rate at 17.6% and mortality at 2.9%, respectively.
Our single-center study illustrated the feasibility and safety of ICVA recanalization. Great care should be taken as revascularization is of high risk. When patient selection, occlusion course and stage as well as neuroimaging evaluation are considered, endovascular recanalization may be a useful therapeutic modality.
颅内椎动脉(ICVA)慢性症状性完全闭塞的最佳治疗方法仍未确定。我们报告了单一中心对药物治疗无效的慢性症状性 ICVA 闭塞患者进行血管内再通的经验。
2009 年 1 月至 2017 年 1 月,我们回顾性分析了 14 例连续出现与慢性 ICVA 闭塞相关的复发性症状的患者。同时,我们在同期使用 PubMed 数据库搜索了相关文献。
14 例患者中有 11 例在首次出现症状至介入治疗的时间少于 90 天。在 13 例患者中,通过同时进行的双血管造影或高分辨率磁共振成像(HRMRI)推断闭塞的过程。9 例患者的闭塞部位超过后下小脑动脉(PICA)起源,5 例患者的闭塞部位位于 PICA 起源近端。再通的技术成功率为 85.7%(12/14)。2 例患者(14.3%,2/14)发生围手术期并发症:1 例出现短暂性脑缺血发作,1 例出现穿支闭塞综合征。使用基于关键字的搜索,我们在同期确定了 6 项研究。共有 34 例患者接受了再通治疗,再通成功率为 94.1%,围手术期并发症发生率为 17.6%,死亡率为 2.9%。
我们的单中心研究说明了 ICVA 再通的可行性和安全性。由于再通风险较高,应谨慎操作。当考虑患者选择、闭塞过程和阶段以及神经影像学评估时,血管内再通可能是一种有用的治疗方式。